Vietnam is emerging as one of the fastest-growing pharmaceutical markets in Southeast Asia. Rising healthcare demands, coupled with ongoing policy reforms, are creating exciting new opportunities. However, these developments also present significant challenges that businesses in the industry must navigate. So, what does it take to unlock the full potential of this dynamic and fast-evolving market?

Our guest on this week’s English edition of Vietnam Innovators is Ms. Katharina Geppert, Managing Director, MSD Vietnam, who has spent over four years living and working in Vietnam. Drawing from her leadership experience across multiple major markets, Ms. Geppert offers valuable insights into MSD’s growth strategies, emerging trends in the pharmaceutical industry, and the collaborative opportunities between businesses and policymakers to build a more sustainable healthcare ecosystem for Vietnam.

Thank you MSD Vietnam for accompanying Vietnam Innovators. MSD, known as Merck & Co., Inc., Rahway, NJ, USA in the United States and Canada, is one of the premier research-intensive biopharmaceutical companies in the world. With more than 130 years of experience, MSD is at the forefront of research, delivering innovative health solutions that advance the prevention and treatment of diseases in both people and animals. The company fosters a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities. For more information, please visit www.msd.com and http://www.msd-vietnam.com; and connect with the MSD team on Twitter, LinkedIn, and YouTube...

—

Listen to this episode on ⁠YouTube⁠

And explore many amazing articles about the pioneers at: ⁠⁠https://vietcetera.com/vn/bo-suu-tap/vietnam-innovator⁠

Feel free to leave any questions or invitations for business cooperation at ⁠hello@⁠⁠vni-digest.com